Tuberculosis: Evidence review for newly arriving immigrants and refugees

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 12, 2011, Pages

  Greenaway, Christina ^a   Sandoe, Amelia ^a   Vissandjee, Bilkis ^b   Kitai, Ian ^c   Gruner, Doug ^d   Wobeser, Wendy ^e   Pottie, Kevin ^f   Ueffing, Erin ^f   Menzies, Dick ^g   Schwartzman, Kevin ^g  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e QUEEN S UNIVERSITY   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

CANADA; CULTURAL ANTHROPOLOGY; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH PROGRAM; HUMAN; IMMIGRANT; LATENT TUBERCULOSIS; LIVER TOXICITY; PATIENT COMPLIANCE; PATIENT MONITORING; PRIMARY MEDICAL CARE; REFUGEE; REVIEW; RISK BENEFIT ANALYSIS; SCREENING TEST; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); TUBERCULOSIS;

EID: 80052544342     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.090302     Document Type: Review

References (148)

1. Menzies D., Oxlade O., Lewis M. Costs for tuberculosis care in Canada. Ottawa (ON): Public Health Agency of Canada; 2006.
2. Canadian tuberculosis standards. 6th ed. Ottawa (ON): Tuberculosis Prevention and Control, Public Health Agency of Canada, Canadian Lung Association/Canadian Thoracic Society; 2007.
3. Public Health Agency of Canada. Tuberculosis in Canada 2006: pre-release. Ottawa (ON): The Agency; 2007.
4. Tugwell P., Pottie K., Welch V., et al. Evaluation of evidence-based literature andformation of recommendations for the Clinical Preventive Guidelines for Immigrants and Refugees in Canada. CMAJ 2010 June 23 [Epub ahead of print].
5. Controlling tuberculosis in the United States: Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Morb Mortal Wkly Rep 2005;54(RR-12):1-81.
6. Recommendations for prevention and control of tuberculosis among foreign-born persons. Report of the Working Group on Tuberculosis Among Foreign-Born Persons. MMWR Morb Mortal Wkly Rep 1998;47(RR-16):1-29.
7. Dasgupta K., Menzies D. Cost-effectiveness of tuberculosis control strategies among immigrants and refugees. Eur Respir J 2005;25:1107-1116 (Pubitemid 40823787)
8. Cain K.P., Haley C.A., Armstrong L.R., et al. Tuberculosis among foreign-born persons in the United States: Achieving tuberculosis elimination. Am J Respir Crit Care Med 2007;175:75-79 (Pubitemid 46105312)
9. Thomas R.E., Gushulak B. Screening and treatment of immigrants and refugees to Canada for tuberculosis: Implications of the experience of Canada and other industrialized countries. Can J Infect Dis 1995;6:246-255
10. Canadian guidelines for the investigation and follow-up of individuals under medical surveillance for tuberculosis after arrival in Canada. Can Commun Dis Rep 2001;27:157-165
11. Walker P.F., Jaranson J. Refugee and immigrant health care. Med Clin North Am 1999;83:1103-1120,viii. (Pubitemid 29356956)
12. Barnett E. Infectious disease screening for refugees resettled in the United States. Clin Infect Dis 2004;39:833-841 (Pubitemid 39244299)
13. Stauffer W.M., Kamat D., Walker P.F. Screening of international immigrants, refugees, and adoptees. Prim Care 2002;29:879-905. (Pubitemid 36083489)
14. Menzies D., Pai M., Comstock G. Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340-354 (Pubitemid 351650594)
15. Pai M., Zwerling A., Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update. Ann Intern Med 2008;149: 177-184
16. Wang L., Turner M., Elwood R., et al. A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax 2002; 57:804-809 (Pubitemid 34984980)
17. Farhat M., Greenaway C., Pai M., et al. False-positive tuberculin skin tests: What is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006;10:1192-1204 (Pubitemid 44713473)
18. Joos T.J., Miller W.C., Murdoch D.M. Tuberculin reactivity in bacille Calmette- Guerin vaccinated populations: A compilation of international data. Int J Tuberc Lung Dis 2006;10:883-891 (Pubitemid 44197849)
19. Tan L., Altman R., Nielsen N.; Council on Scientific Affairs AMA. Screening nonimmigrant visitors to the United States for tuberculosis: Report of the Council on Scientific Affairs. Arch Intern Med 2001;161:334-340 (Pubitemid 32116548)
20. Heywood N., Kawa B., Long R., et al. Guidelines for the investigation and follow-up of individuals under medical surveillance for tuberculosis after arriving in Canada: A summary. CMAJ 2003;168:1563-1565 (Pubitemid 36741196)
21. Watkins R.E., Brennan R., Plant A.J. Tuberculin reactivity and the risk of tuberculosis: A review. Int J Tuberc Lung Dis 2000;4:895-903.
22. Jeon C.Y., Murray M.B. Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies. PLoS Med 2008;5:e152.
23. Morrison J., Pai M., Hopewell P.C. Tuberculosis and latent tuberculosis infection in close contacts of people with pumonary tuberculosis in low-income and middleincome countries: A systematic review and meta-analysis. Lancet Infect Dis 2008;8:359-368
24. Smieja M.J., Marchetti C.A., Cook D.J., et al. Isoniazid for preventing tuberculosis in non-HIV infected persons [review]. Cochrane Database Syst Rev 1999(1):CD001363.
25. Hirsch-Moverman Y., Daftary A., Franks J., et al. Adherence to treatment for latent tuberculosis infection: Systematic review of studies in the US and Canada. Int J Tuberc Lung Dis 2008;12:1235-1254
26. American Thoracic Society, Centers for Disease Control and Prevention/Infectious Diseases Society of America. Controlling tuberculosis in the United States. Am J Respir Crit Care Med 2005;172:1169-1227
27. American Thoracic Society. Targeted tuberculin testing and treatment of tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-S247
28. Pediatric Tuberculosis Collaborative Group. Targeted tuberculin skin testing and treatment of latent tuberculosis infection in children and adolescents. Pediatrics 2004;114:1175-1201
29. World Health Organization. WHO Report 2008. Global tuberculosis control. Surveillance, planning, financing. Geneva (Switzerland): The Organization; 2008.
30. Public Health Agency of Canada. Tuberculosis in Canada 2004. Ottawa (ON): The Agency; 2007.
31. Tuberculosis and respiratory diseases. Tuberculosis in Canada 2000. Ottawa (ON): Health Canada; 2003.
32. Creatore M.I., Lam M., Wobeser W.L. Patterns of tuberculosis risk over time among recent immigrants to Ontario, Canada. Int J Tuberc Lung Dis 2005;9:667-672 (Pubitemid 40826160)
33. Farah M.G., Meyer H.E., Selmer R., et al. Long-term risk of tuberculosis among immigrants in Norway. Int J Epidemiol 2005;34:1005-1011 (Pubitemid 41535544)
34. Tuberculosis among Indochinese refugees-an update. MMWR Morb Mortal Wkly Rep 1981;30:603-606
35. Enarson D.A. Active tuberculosis in Indochinese refugees in British Columbia. CMAJ 1984;131:39-42. (Pubitemid 14090640)
36. Wilcke J.T., Poulsen S., Askgaard D.S., et al. Tuberculosis in a cohort of Vietnamese refugees after arrival in Denmark 1979-1982. Int J Tuberc Lung Dis 1998;2:219-224 (Pubitemid 28123521)
37. Thorpe L.E., Laserson K., Cookson S., et al. Infectious tuberculosis among newlyarrived refugees in the United States. N Engl J Med 2004;350:2105-2106 (Pubitemid 38596571)
38. Marras T.K., Wilson J., Wang E.E.L., et al. Tuberculosis among Tibetan refugee claimants in Toronto: 1998 to 2000. Chest 2003;124:915-921 (Pubitemid 37123309)
39. Hadzibegovic D.S., Maloney S.A., Cookson S.T., et al. Determining TB rates and TB case burden for refugees. Int J Tuberc Lung Dis 2005;9:409-414 (Pubitemid 40524032)
40. Menzies D., Gardiner G., Farhat M., et al. Thinking in three dimensions: A webbased algorithm to aid the interpretation of tuberculin skin test results. Int J Tuberc Lung Dis 2008;12:498-505. (Pubitemid 351703056)
41. Guelar A., Gatell J., Verdejo J., et al. A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS 1993;7:1345-1349 (Pubitemid 23330305)
42. Antonucci G., Girardi E., Raviglione M., et al. Risk factors for tuberculosis in HIVinfected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA 1995;274:143-148
43. Selwyn P.A., Hartel D., Lewis V.A. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-550 (Pubitemid 19070537)
44. Wood R., Maartens G., Lombard C. Risk factors for developing tuberculosis in HIV-1-infected adults from communities with low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr 2000;23:75-80. (Pubitemid 30123268)
45. Sakhuja V., Jha V., Varma P., et al. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996;61:211-215 (Pubitemid 26044532)
46. Aguado J.M., Herrero J.A., Gavalda J., et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Transplantation 1997;63:1278-1286 (Pubitemid 27212823)
47. Meyers B.R., Halpern M., Sheiner P., et al. Tuberculosis in liver transplant patients. Transplantation 1994;58:301-306 (Pubitemid 24252281)
48. Miller R.A., Lanza L.A., Kline J.N., et al. Mycobacterium tuberculosis in lung transplant recipients. Am J Respir Crit Care Med 1995;152:374-376
49. Ruiz-Argüelles GJ, Mercado-DÍaz MA, Ponce-De-León S, et al. Studies on lymphomata, III: Lymphomata, granulomata and tuberculosis. Cancer 1983;52:258-262
50. Morrow L.B., Anderson R.E. Active tuberculosis in leukemia: Malignant lymphoma and myelofibrosis. Arch Pathol 1965;79:484-493
51. Cowie R.L. The epidemiology of tuberculosis in gold miners with silicosis. Am J Respir Crit Care Med 1994;150:1460-1462 (Pubitemid 24356669)
52. Hong Kong Chest Service/Tuberculosis Research Centre MBMRC. A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Respir Dis 1992;145:36-41.
53. Malhotra K.K., Parashar M.K., Sharma R.K., et al. Tuberculosis in maintenance haemodialysis patients. Study from an endemic area. Postgrad Med J 1981;57:492-498 (Pubitemid 11090770)
54. Lundin A.P., Adler A.J., Berlyne G.M., et al. Tuberculosis in patients undergoing maintenance hemodialysis. Am J Med 1979;67:597-602. (Pubitemid 10249297)
55. Andrew O.T., Schoenfeld P.Y., Hopewell P.C., et al. Tuberculosis in patients with end-stage renal disease. Am J Med 1980;68:59-65. (Pubitemid 10207619)
56. Pradhan R.P., Katz L.A., Nidus B.D., et al. Tuberculosis in dialyzed patients. JAMA 1974;229:798-800.
57. Rieder H.L., Cauthen G.M., Comstock G.W., et al. Epidemiology of tuberculosis in the United States. Epidemiol Rev 1989;11:79-98. (Pubitemid 19279007)
58. Sutherland I. The evolution of clinical tuberculosis in adolescents. Tubercle 1966; 47:308.
59. Sutherland I. Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Adv Tuberc Res 1976;19:1-63.
60. Grzybowksi S., McKinnon N.E., Tuters L., et al. Reactivations in inactive pulmonary tuberculosis. Am Rev Respir Dis 1966;93:352-360
61. Grzybowski S., Fishaut H., Rowe J., et al. Tuberculosis among patients with various radiologic abnormalities, followed by the chest clinic service. Am Rev Respir Dis 1971;104:605-608
62. Nolan C.M., Elarth A.M. Tuberculosis in a cohort of Southeast Asian refugees. A five-year surveillance study. Am Rev Respir Dis 1988;137:805-809 (Pubitemid 18099289)
63. Keane J., Gershon S., Wise R., et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-1104
64. Brassard P., Kezouh A., Suissa S. Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis 2006;43:717-722 (Pubitemid 44330734)
65. Carmona L., Gómez-Reino J., Rodríguez-Valverde V., et al. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 2005;52:1766-1772 (Pubitemid 40852885)
66. Wolfe F., Michaud K., Anderson J., et al. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum 2004;50:372-379 (Pubitemid 38198820)
67. Jick S.S., Lieberman E.S., Rahman M.U., et al. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum 2006;55:19-26. (Pubitemid 43235123)
68. Pablos-Mendez A., Blustein J., Knirsch C.A. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 1997;87: 574-579 (Pubitemid 27208742)
69. Kim S.J., Hong Y.P., Lew W.J., et al. Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis 1995;76:529-533 (Pubitemid 26008709)
70. Boucot K.R. Diabetes mellitus and pulmonary tuberculosis. J Chronic Dis 1957;6: 256-279
71. Silwer H., Oscarsson P.N. Incidence and coincidence of diabetes mellitus and pulmonary tuberculosis in a Swedish county. Acta Med Scand 1958;335:1-48.
72. Comstock G.W., Livesay V.T., Woolpert S.F. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974;99:131-138
73. Comstock G.W. Frost revisited: The modern epidemiology of tuberculosis. Am J Epidemiol 1975;102:363-382
74. Palmer C.E., Jablon S., Edwards P.Q. Tuberculosis morbidity of young men in relation to tuberculin sensitivity and body build. Am Rev Tuberc 1957;76:517-539
75. Edwards L.B., Livesay V.T., Acquaviva F.A., et al. Height, weight, tuberculous infection, and tuberculous disease. Arch Environ Health 1971;22:106-112
76. Maurya V., Vijayan V., Shah A. Smoking and tuberculosis: An association overlooked. Int J Tuberc Lung Dis 2002;6:942-951 (Pubitemid 35408179)
77. Bates M.N., Khalakdina A., Pai M., et al. Risk of tuberculosis from exposure to tobacco smoke: A systematic review and meta-analysis. Arch Intern Med 2007;167: 335-342 (Pubitemid 46333932)
78. Horwitz O., Wilbek E., Erickson P. Epidemiological basis of tuberculosis eradication. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area. Bull World Health Organ 1969;41:95-113.
79. Truong D.H., Hedemark L.L., Mickman J.K., et al. Tuberculosis among Tibetan immigrants from India and Nepal in Minnesota, 1992-1995. JAMA 1997;277:735-738 (Pubitemid 27106226)
80. Comstock G.W., Edwards L.B., Livesay V.T. Tuberculosis morbidity in the US Navy: Its distribution and decline. Am Rev Respir Dis 1974;110:572-580
81. Marcus J.H., Khassis Y. Tuberculin sensitivity in BCG vaccinated infants and children in Israel. Acta Tuberc Pneumol Scand 1965;46:113-122
82. Karalliede S., Katugha L.P., Uragoda C.G. Tuberculin response of Sri Lankan children after BCG vaccination at birth. Tubercle 1987;68:33-38 (Pubitemid 17040413)
83. Reid J.K., Ward H., Marciniuk D., et al. The effect of neonatal BCG vaccination on PPD testing on Canadian Aboriginal children. Chest 2007;131:1806-1810
84. Sepulveda R.L., Ferrer X., Latrach C., et al. The influence of Calmette-Guérin bacillus immunization on the booster effect of tuberculin testing in healthy young adults. Am Rev Respir Dis 1990;142:24-28 (Pubitemid 20224573)
85. Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2008; 34:1-13.
86. Oxlade O., Schwartzman K., Menzies D. Interferon-gamma release assays and TB screening in high-income countries: A cost-effectiveness analysis. Int J Tuberc Lung Dis 2007;11:16-26. (Pubitemid 46101841)
87. Bucher H.C., Griffith L.E., Guyatt G.H., et al. Isoniazid prophylaxis for tuberculosis in HIV infection: A meta-analysis of randomized controlled trials. AIDS 1999;13 (4): 501-507
88. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: Five years of follow- up in the IUAT trial. Bull World Health Organ 1982;60:555-564
89. Comstock G.W. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis 1999;3:847-850 (Pubitemid 29488035)
90. Public Health Agency of Canada. Tuberculosis drug resistance in Canada 2007. Ottawa (ON): The Agency; 2007.
91. Khan K., Muennig P., Behta M., et al. Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States. N Engl J Med 2002;347:1850-1859 (Pubitemid 35417777)
92. Fountain F.F., Tolley E., Chrsman C.R., et al. Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: A 7-year evaluation from a public health tuberculosis clinic. Chest 2005;128:116-123 (Pubitemid 40994462)
93. Horsburgh C.R. Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004;350:2060-2067
94. Nolan C.M., Goldberg S.V., Buskin S.E. Hepatotoxicity associated with isoniazid preventive therapy: A 7-year survey from a public health tuberculosis clinic. JAMA 1999;281:1014-1018 (Pubitemid 29143893)
95. LoBue P.A., Moser K.S. Use of isoniazid for latent tuberculosis infection in a public health clinic. Am J Respir Crit Care Med 2003;168:443-447 (Pubitemid 37046873)
96. Saukkonen J., Cohn D., Jasmer R., et al. An official ATS statement: Hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 2006;174:935-952 (Pubitemid 44564795)
97. Wu S.S., Chao C.S., Vargas J.H., et al. Isoniazid-related hepatic failure in children: A survey of liver transplantation centers. Transplantation 2007;84:173-179 (Pubitemid 47205750)
98. Palusci V.J., Ohare D., Lawrence R.M. Hepatotoxicity and transaminase measurement during isoniazid chemoprophylaxis in children. Pediatr Infect Dis J 1995;14: 144-148
99. Kopanoff D.E., Snider D.E. Jr, Caras G.J. Isoniazid-related hepatitis: A U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978;117:991-1001. (Pubitemid 8380195)
100. Comstock G.W. Prevention of tuberculosis among tuberculin reactors: Maximizing benefits, minimizing risks. JAMA 1986;256:2729-2730 (Pubitemid 17178094)
101. Nakajo M.M., Rao M., Steiner P. Incidence of hepatotoxicity in children receiving isoniazid chemoprophylaxis. Pediatr Infect Dis J 1989;8:649-650 (Pubitemid 19227821)
102. Spyridis P., Sinaniotis C., Papadea I., et al. Isoniazid liver injury during chemoprophylaxis in children. Arch Dis Child 1979;54:65-67 (Pubitemid 9083127)
103. Litt I.F., Cohen M.I., McNamara H. Isoniazid hepatitis in adolescents. J Pediatr 1976;89:133-135
104. Beaudry P.H., Brickman H.F., Wise M.B., et al. Liver enzyme disturbances during isoniazid chemoprophylaxis in children. Am Rev Respir Dis 1974;110:581-584
105. Hsu K.H. Isoniazid in the prevention and treatment of tuberculosis. A 20-year study of the effectiveness in children. JAMA 1974;229:528-533
106. Richards B., Kozak R., Brassard P., et al. Tuberculosis surveillance among new immigrants in Montreal. Int J Tuberc Lung Dis 2005;9:858-864 (Pubitemid 41139643)
107. Dasgupta K., Schwartzman K., Marchand R., et al. Comparison of cost-effectivenss of tuberculosis screening of close contacts and foreign-born populations. Am J Respir Crit Care Med 2000;162:2079-2086 (Pubitemid 32054359)
108. Wells C.D., Zuber P.L., Nolan C.M., et al. Tuberculosis prevention among foreign-born persons in Seattle-King County, Washington. Am J Respir Crit Care Med 1997; 156: 573-577 (Pubitemid 27351997)
109. Saraiya M., Cookson S., Tribble P., et al. Tuberculosis screening among foreignborn persons applying for permanent US residence. Am J Public Health 2002;92: 826-829 (Pubitemid 34441638)
110. Blum R.N., Polish L.B., Tapy J.M., et al. Results of screening for tuberculosis in foreign- born persons applying for adjustment of immigration status. Chest 1993;103: 1670-1674 (Pubitemid 23174295)
111. Brassard P., Steensma C., Cadieux L., et al. Evaluation of a school-based tuberculosis- screening program and associate investigation targeting recently immigrated children in a low-burden country. Pediatrics 2006;117:e148-e156 (Pubitemid 46071568)
112. Yuan L., Richardson E., Kendall P. Evaluation of a tuberculosis screening program for high-risk students in Toronto schools. CMAJ 1995;153:925-932
113. Sipan C., Blumberg E., Hovell M., et al. Screening Latino adolescents for latent tuberculosis infection (LTBI). Public Health Rep 2003;118:425-433 (Pubitemid 37059477)
114. Gounder C.R., Driver C.R., Scholten J.N., et al. Tuberculin testing and risk of tuberculosis infection among New York City schoolchildren. Pediatrics 2003;111:e309-e315
115. Chang S., Wheeler L., Farrell K. Public health impact of targeted tuberculosis screening in public schools. Am J Public Health 2002;92:1942-1945 (Pubitemid 35386619)
116. Adhikari N., Menzies R. Community-based tuberculin screening in Montreal: A cost-outcome description. Am J Public Health 1995;85:786-790
117. D'Lugoff M.I., Jones W., Kub J., et al. Tuberculosis screening in an at-risk immigrant Hispanic population in Baltimore city: An academic health center/local health department partnership. J Cult Divers 2002;9:79-85.
118. El-Hamad I., Casalini C., Matteelli A., et al. Screening for tuberculosis and latent tuberculosis infection among undocumented immigrants at an unspecialised health service unit. Int J Tuberc Lung Dis 2001;5:712-716 (Pubitemid 32720554)
119. Jereb J., Etkind S., Joglar O., et al. Tuberculosis contact investigations: Outcomes in selected areas of the United States, 1999. Int J Tuberc Lung Dis 2003;7(Suppl 3): S384-S390 (Pubitemid 38004714)
120. Poss J.E. Factors associated with participation by Mexican migrant farmworkers in a tuberculosis screening program. Nurs Res 2000;49:20-28
121. Carvalho A.C., Saleri N., El-Hamad I., et al. Completion of screening for latent tuberculosis infection among immigrants. Epidemiol Infect 2005;133:179-185 (Pubitemid 40276988)
122. Doering D., Kocuipchyk R., Lester S. A tuberculosis screening and chemoprophylaxis project in children from a high risk population in Edmonton, Alberta. Can J Public Health 1999;90:152-155 (Pubitemid 29319892)
123. Levesque J.F., Dongier P., Brassard P., et al. Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada. Int J Tuberc Lung Dis 2004;8:711-717 (Pubitemid 38750206)
124. Long R., Sutherland K., Kunimoto D., et al. The epidemiology of tuberculosis among foreign-born persons in Alberta, Canada, 1989-1998: Identification of high risk groups. Int J Tuberc Lung Dis 2002;6:615-621 (Pubitemid 36898187)
125. Uppaluri A., Naus M., Heywood N., et al. Effectiveness of the immigration medical surveillance program for tuberculosis in Ontario. Can J Infect Dis 2002;93:88-91. (Pubitemid 34552400)
126. Orr P.H., Manfreda J., Hershfield E.S. Tuberculosis surveillance in immigrants to Manitoba. CMAJ 1990;142:453-458 (Pubitemid 20077832)
127. Wobeser W.L., Yuan L., Naus M., et al. Expanding the epidemiologic profile: Risk factors for active tuberculosis in people immigrating to Ontario. CMAJ 2000;163: 823-828
128. Enarson D., Ashley M., Grzybowski S. Tuberculosis in immigrants to Canada. A study of present-day patterns in relation to immigration trends and birthplace. Am Rev Respir Dis 1979;119:11-18 (Pubitemid 9116304)
129. Lobato M.N., Hopewell P.C. Mycobacterium tuberculosis infection after travel to or contact with visitors from countries with a high prevalence of tuberculosis. Am J Respir Crit Care Med 1998;158:1871-1875 (Pubitemid 29008827)
130. Statistics Canada, Culture, Tourism and the Centre for Education Statistics, International Travel Section. International Travel 2006:1-86.
131. Cobelens F.G., VanDeutekom H., Draayer-Jansen I.W., et al. Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity. Lancet 2000;356:461-465 (Pubitemid 30496817)
132. Loeffler A.M. Pediatric tuberculosis. Semin Respir Infect 2003;18:272-291 (Pubitemid 38018771)
133. Mandalakas A.M., Starke J.R. Current concepts of childhood tuberculosis. Semin Pediatr Infect Dis 2005;16:93-104.
134. Wyss L.L., Alderman M.K. Using theory to interpret beliefs in migrants diagnosed with latent TB. Online J Issues Nurs 2006;12:7.
135. Brewin P., Jones A., Kelly M., et al. Is screening for tuberculosis acceptable to immigrants? A qualitative study. J Public Health (Oxf) 2006;28:253-260 (Pubitemid 44408930)
136. Coreil J., Lauzardo M., Heurtelou M. Cultural feasibility assessment of tuberculosis prevention among persons of Haitian origin in South Florida. J Immigr Health 2004; 6: 63-69
137. Griffiths C., Sturdy P., Brewin P., et al. Educational outreach to promote screening for tuberculosis in primary care: A cluster randomised controlled trial. Lancet 2007; 369: 1528-1534 (Pubitemid 46670302)
138. LoBue P.A., Moser K., Catanzaro A. Management of tuberculosis in San Diego County: A survey of physicians' knowledge, attitudes and practices. Int J Tuberc Lung Dis 2001;5:933-938 (Pubitemid 32976638)
139. Gany F.M., Trinh-Shevrin C., Changrani J. Drive-by readings: A creative strategy for tuberculosis control among immigrants. Am J Public Health 2005;95:117-119 (Pubitemid 40075892)
140. Ailinger R.L., Dear M.R. Adherence to tuberculosis preventive therapy among Latino immigrants. Public Health Nurs 1998;15:19-24. (Pubitemid 128456535)
141. Pang S.C., Harrison R.H., Brearley J., et al. Preventive therapy for tuberculosis in Western Australia. Int J Tuberc Lung Dis 1998;2:984-988 (Pubitemid 29005214)
142. Shieh F.K., Snyder G., Horsburgh C.R., et al. Predicting non-completion of treatment for latent tuberculous infection: A prospective survey. Am J Respir Crit Care Med 2006; 174: 717-721 (Pubitemid 44395341)
143. Catlos E.K., Cantwell M.F., Bhatia G., et al. Public health interventions to encourage TB Class A/B1/B2 Immigrants to present for TB screening. Am J Respir Crit Care Med 1998; 158:1037-1041 (Pubitemid 28488998)
144. Cass A.D., Talavera G.A., Gresham L.S., et al. Structured behavioral intervention to increase children's adherence to treatment for latent tuberculosis infection. Int J Tuberc Lung Dis 2005;9:415-420 (Pubitemid 40524033)
145. Hovell M.F., Sipan C.L., Blumberg E.J., et al. Increasing Latino adolescents' adherence to treatment for latent tuberculosis infection: A controlled trial. Am J Public Health 2003; 93:1871-1877 (Pubitemid 38480153)
146. Goldberg S.V., Wallace J., Jackson J.C., et al. Cultural case management of latent tuberculosis infection. Int J Tuberc Lung Dis 2004;8:76-82. (Pubitemid 38120709)
147. Wobeser W., Yuan L., Gushulak B., et al. Surveillance and screening in tuberculosis control. In: Long R, Ellis E, editors. The Canadian tuberculosis standards, 6th ed. Ottawa (ON): Health Canada and the Canadian Lung Association; 2007. p. 274-297
148. Guidelines for using the QuantiFERON®-TB gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Morb Mortal Wkly Rep 2005;54 (RR-15): 49-55.